FDA grants accelerated approval of Biogen's treatment for a rare form of ALS
The U.S. Food and Drug Administration said Tuesday it has granted accelerated approval to Biogen Inc.’s torferson, a treatment for a rare form of amyotrophic lateral sclerosis, or ALS.
The accelerated program is used to approve drugs for serious conditions that have an unmet medical need, where a drug is shown to have an effect on an endpoint that is reasonably likely to predict a clinical benefit to patients.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the diseaseThe FDA's approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.
Lire la suite »
FDA grants accelerated approval to Biogen’s treatment for rare form of ALSThe U.S. Food and Drug Administration said Tuesday it has granted accelerated approval to Biogen Inc.’s torferson, a treatment for a rare form of amyotrophic...
Lire la suite »
Biogen tops estimates as revenue slides 3% from a year agoBiogen Inc. said Tuesday it had net income of $387.9 million, or $2.67 a share, for the first quarter, up from $303.8 million, or $2.06 a share, in the...
Lire la suite »
Foghorn Therapeutics stock slides 21% after FDA puts partial clinical hold on cancer drug trialFoghorn Therapeutics Inc.’s stock slid 21% in premarket trade Monday, after the biotech said the Food and Drug Administration has placed a partial hold on a...
Lire la suite »
Kamala Harris says wrong name for FDA in interview about mifepristoneHarris mistakenly said the Federal Drug Administration approved the abortion pill mifepristone more than two decades ago — but such an agency doesn’t exist.
Lire la suite »
FDA Okays Latest Artificial Pancreas, the MiniMed 780GThe updated automated insulin delivery system features so-called meal detection technology and 7-day wear for the insulin pump.
Lire la suite »